Twist Bioscience (TWST) Return on Capital Employed (2018 - 2026)
Twist Bioscience (TWST) reported Return on Capital Employed of 25.84% for Q1 2026, up 1232.0% year-over-year from 1.94% in Q1 2025, and down 7.49% quarter-over-quarter from 24.04% in Q4 2025.
Twist Bioscience (TWST) Return on Capital Employed (2018 - 2026) Analysis & Trends
Twist Bioscience (TWST) has 9 years of Return on Capital Employed data on file, last reported at 25.84% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 25.84%, up 1232.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 25.84% (up 1232.0% YoY), and the FY2025 annual result was 25.39%, up 998.0% from the prior year.
- Return on Capital Employed slipped to 25.84% in Q1 2026 per TWST's latest filing, from 24.04% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 23.98% in Q2 2022 and troughed at 39.77% in Q3 2024.
- A 5-year average of 29.96% and a median of 27.7% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed sank 987 bps in 2024, then jumped 1506 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 26.23% in 2022, then slipped by 21 bps to 31.84% in 2023, then declined by 21 bps to 38.48% in 2024, then soared by 38 bps to 24.04% in 2025, then retreated by 7 bps to 25.84% in 2026.
- Business Quant data shows TWST's Return on Capital Employed at 25.84% in Q1 2026, 24.04% in Q4 2025, and 24.71% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 67.98% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 14.57% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -3.63% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 10.24% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 45.73% |
| 10 | Twist Bioscience | 4.30 Bn | 4.30 Bn | 57.12 Mn | -25.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.84% |
| Dec 31, 2025 | -24.04% |
| Sep 30, 2025 | -24.71% |
| Jun 30, 2025 | -26.73% |
| Mar 31, 2025 | -38.16% |
| Dec 31, 2024 | -38.48% |
| Sep 30, 2024 | -39.77% |
| Jun 30, 2024 | -39.36% |
| Mar 31, 2024 | -31.79% |
| Dec 31, 2023 | -31.84% |
| Sep 30, 2023 | -30.16% |
| Jun 30, 2023 | -29.49% |
| Mar 31, 2023 | -27.70% |
| Dec 31, 2022 | -26.23% |
| Sep 30, 2022 | -26.68% |
| Jun 30, 2022 | -23.98% |
| Mar 31, 2022 | -24.25% |
| Dec 31, 2021 | -26.48% |
| Sep 30, 2021 | -23.47% |
| Jun 30, 2021 | -21.17% |